Challenges encountered in the implementation of bio-fluorescent particle counting systems as a routine microbial monitoring tool
Broadcast date
Wed, Oct 26, 2022
Presented by
- Allison Scott - MicronViewJoanny Salvas - PfizerPhil Villari - Merck & Co., Inc
Quick Description
In this webinar, potential challenges during the implementation of a bio-fluorescent particle counting system are discussed, sharing the perspective of a consortium of four industry-working groups on navigating these challenges.
Details
In this webinar, potential challenges during the implementation of a bio-fluorescent particle counting system are discussed, sharing the perspective of a consortium of four industry-working groups on navigating these challenges.
Bio-fluorescent particle counting technologies use the detection of intrinsic fluorescence to continuously enumerate bioburden levels in air or water samples. The reported unit is commonly referred to as an auto-fluorescence unit, which is not dependent upon growth like the traditional method. Examples of challenges include the perceived risk of regulatory inspectional observations and lack of acceptance, internal communication and acceptance, qualification strategy, and validation of a modern method that reports in a non-growth-based unit.
Information is shared on ways to navigate common challenges encountered during the implementation of new technologies, on a BFPC modern microbiological method, and an industry working group collaboration that offers support to the industry with the implementation and use of modern microbial methods.
Speakers
Allison Scott
MicronView
Joanny Salvas
Pfizer
Phil Villari
Merck & Co., Inc